Skip to main content
. 2013 Jan 18;15(11):858–864. doi: 10.1111/hpb.12047

Table 3.

Occurrence of sinusoidal obstruction syndrome (SOS) by grade in patients treated with oxaliplatin with and without bevacizumab

Oxaliplatin alone (n = 67) Oxaliplatin + bevacizumab (n = 10) P-value
Group 1 (SOS grade 0, n = 35), n 7 4 0.003
Group 2 (SOS grade 1, n = 49), n 23 5
Group 3 (SOS grade 2, n = 51), n 28 1
Group 4 (SOS grade 3, n = 16), n 9 0